US equities |
NVDA $233.95 ▲+1.34% MU $1,074.89 ▼-2.05% TSLA $370.59 ▲+4.65% SPCX $158.96 ▲+7.35% SNDK $1,719.99 ▼-3.79% AMD $633.91 ▲+2.95% STX $848.99 ▼-10.21% INTC $119.33 ▼-0.56%
FinancialContent

ANI Pharmaceuticals, Inc. - Common Stock (NQ:ANIP)

72.18 -0.78 (-1.07%)
Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ANI Pharmaceuticals, Inc. - Common Stock

< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >
News headline image
ANI Pharmaceuticals Reports First Quarter 2021 Results
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
Earnings Outlook for ANI Pharmaceuticals ↗
On Friday, May 07, ANI Pharmaceuticals (NASDAQ:ANIP) will release its latest earnings report. Here is Benzinga's outlook for the company. What Are Earnings, Net Income, And... 
Via Benzinga
News headline image
ANI Pharmaceuticals to Discuss First Quarter 2021 Financial Results on May 7, 2021
From ANI Pharmaceuticals, Inc.
Via Business Wire
News headline image
Earnings Scheduled For May 7, 2021 ↗
Companies Reporting Before The Bell • Cronos Group (NASDAQ:CRON) is likely to report earnings for its first quarter. • Eaton Vance Municipal (NYSE:ETX) is... 
Via Benzinga
News headline image
Week Ahead In Biotech (May 2-8): ChemoCentryx Adcom, Ophthalmology Conference Presentations, Earnings Deluge ↗
Biopharma stocks experienced volatility in the week ended April 30, as stocks reacted to earnings, data readouts and a handful of FDA decisions. Earnings prints from big name... 
Via Benzinga
< Previous 1 2
...
4 5 6 7 8 9 10 11 Next >